VivoSeq
Other

Silver Diamine Fluoride

0

Pipeline Programs

6

Active Trials

0

Companies Involved

Silver Diamine Fluoride is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

7/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

29

clinical trials

Completed12 · 41%
Unknown status8 · 28%
Active, not recruiting3 · 10%
Not yet recruiting2 · 7%
Terminated1 · 3%
Withdrawn1 · 3%
Other2 · 7%

Trial Activity

29 trials

Comparison of Cariostatic Effect of Nano-Silver Fluoride Versus Silver Diamine Fluoride
Active, not recruiting··Phase 1·NCT05941429·78 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)